Vincent Medical Holdings Limited
HKEX:1612.HK
0.395 (HKD) • At close September 16, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 717.973 | 629.242 | 777.72 | 1,155.383 | 502.2 | 488.03 | 446.302 | 467.347 | 448.169 | 388.977 | 324.492 |
| Cost of Revenue
| 495.382 | 481.411 | 533.887 | 676.595 | 340.747 | 332.422 | 295.999 | 321.585 | 308.368 | 273.913 | 236.293 |
| Gross Profit
| 222.591 | 147.831 | 243.833 | 478.788 | 161.453 | 155.608 | 150.303 | 145.762 | 139.801 | 115.064 | 88.199 |
| Gross Profit Ratio
| 0.31 | 0.235 | 0.314 | 0.414 | 0.321 | 0.319 | 0.337 | 0.312 | 0.312 | 0.296 | 0.272 |
| Reseach & Development Expenses
| 36.063 | 36.682 | 39.245 | 35.671 | 29.188 | 26.1 | 19.147 | 9.587 | 7.185 | 7.213 | 7.264 |
| General & Administrative Expenses
| 99.068 | 101.678 | 87.739 | 105.696 | 101.836 | 89.058 | 84.613 | 70.112 | 53.195 | 48.596 | 42.973 |
| Selling & Marketing Expenses
| 38.928 | 31.973 | 37.679 | 54.727 | 32.119 | 27.708 | 23.067 | 15.485 | 14.395 | 14.787 | 11.48 |
| SG&A
| 121.287 | 116.129 | 113.434 | 145.962 | 104.306 | 116.838 | 107.68 | 85.597 | 67.59 | 63.383 | 54.453 |
| Other Expenses
| -0.817 | -2.524 | -11.697 | 5.682 | 2.603 | -2.697 | -0.448 | 0 | 0 | -1.765 | -1.516 |
| Operating Expenses
| 158.167 | 155.335 | 164.376 | 181.633 | 133.494 | 116.849 | 130.457 | 97.784 | 70.755 | 61.618 | 52.937 |
| Operating Income
| 64.424 | -7.504 | 79.457 | 297.155 | 27.959 | 47.118 | 43.065 | 64.915 | 72.701 | 53.998 | 35.555 |
| Operating Income Ratio
| 0.09 | -0.012 | 0.102 | 0.257 | 0.056 | 0.097 | 0.096 | 0.139 | 0.162 | 0.139 | 0.11 |
| Total Other Income Expenses Net
| -0.326 | -6.348 | -7.398 | -8.318 | -7.211 | -8.987 | -23.448 | -17.219 | -3.529 | -0.04 | -0.08 |
| Income Before Tax
| 64.098 | -13.852 | 72.059 | 288.837 | 20.748 | 38.131 | 19.617 | 47.696 | 69.172 | 53.958 | 35.475 |
| Income Before Tax Ratio
| 0.089 | -0.022 | 0.093 | 0.25 | 0.041 | 0.078 | 0.044 | 0.102 | 0.154 | 0.139 | 0.109 |
| Income Tax Expense
| 8.707 | 2.874 | 6.11 | 36.649 | 5.437 | 3.928 | 8.163 | 10.614 | 2.484 | 11.562 | 8.465 |
| Net Income
| 57.275 | -17.398 | 60.695 | 216.865 | 11.525 | 30.943 | 13.155 | 29.242 | 58.153 | 35.759 | 23.413 |
| Net Income Ratio
| 0.08 | -0.028 | 0.078 | 0.188 | 0.023 | 0.063 | 0.029 | 0.063 | 0.13 | 0.092 | 0.072 |
| EPS
| 0.089 | -0.027 | 0.093 | 0.34 | 0.018 | 0.049 | 0.021 | 0.053 | 0.14 | 0.075 | 0.049 |
| EPS Diluted
| 0.089 | -0.027 | 0.092 | 0.33 | 0.018 | 0.049 | 0.021 | 0.053 | 0.14 | 0.075 | 0.049 |
| EBITDA
| 103.076 | 33.448 | 119.52 | 334.171 | 56.512 | 61.815 | 55.708 | 77.531 | 86.013 | 66.368 | 46.379 |
| EBITDA Ratio
| 0.144 | 0.053 | 0.154 | 0.289 | 0.113 | 0.127 | 0.125 | 0.166 | 0.192 | 0.171 | 0.143 |